IL255079A0 - Methods of treating lung cancer - Google Patents

Methods of treating lung cancer

Info

Publication number
IL255079A0
IL255079A0 IL255079A IL25507917A IL255079A0 IL 255079 A0 IL255079 A0 IL 255079A0 IL 255079 A IL255079 A IL 255079A IL 25507917 A IL25507917 A IL 25507917A IL 255079 A0 IL255079 A0 IL 255079A0
Authority
IL
Israel
Prior art keywords
methods
lung cancer
treating lung
treating
cancer
Prior art date
Application number
IL255079A
Other languages
English (en)
Hebrew (he)
Original Assignee
Morphotek Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morphotek Inc filed Critical Morphotek Inc
Publication of IL255079A0 publication Critical patent/IL255079A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57423Specifically defined cancers of lung
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/82Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving vitamins or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL255079A 2015-04-17 2017-10-17 Methods of treating lung cancer IL255079A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562149184P 2015-04-17 2015-04-17
PCT/US2016/027497 WO2016168440A1 (en) 2015-04-17 2016-04-14 Methods for treating lung cancer

Publications (1)

Publication Number Publication Date
IL255079A0 true IL255079A0 (en) 2017-12-31

Family

ID=55809240

Family Applications (1)

Application Number Title Priority Date Filing Date
IL255079A IL255079A0 (en) 2015-04-17 2017-10-17 Methods of treating lung cancer

Country Status (13)

Country Link
US (1) US20180125970A1 (cg-RX-API-DMAC7.html)
EP (1) EP3283886B1 (cg-RX-API-DMAC7.html)
JP (1) JP2018516244A (cg-RX-API-DMAC7.html)
KR (1) KR20170137848A (cg-RX-API-DMAC7.html)
CN (1) CN107624071A (cg-RX-API-DMAC7.html)
AU (1) AU2016248222A1 (cg-RX-API-DMAC7.html)
BR (1) BR112017022320A2 (cg-RX-API-DMAC7.html)
CA (1) CA2983126A1 (cg-RX-API-DMAC7.html)
IL (1) IL255079A0 (cg-RX-API-DMAC7.html)
MX (1) MX2017013390A (cg-RX-API-DMAC7.html)
RU (1) RU2718780C9 (cg-RX-API-DMAC7.html)
SG (1) SG11201708546UA (cg-RX-API-DMAC7.html)
WO (1) WO2016168440A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009521206A (ja) * 2005-04-22 2009-06-04 モルフォテック、インク. 免疫エフェクター活性を有する葉酸受容体アルファ陽性細胞に内部移行する抗体
TW201625301A (zh) * 2014-06-06 2016-07-16 Kyowa Hakko Kirin Co Ltd 藉由folr1標靶藥及葉酸代謝拮抗劑用於癌症患者之治療方法與醫藥
JP7072571B2 (ja) 2016-11-23 2022-05-20 エーザイ・アール・アンド・ディー・マネジメント株式会社 抗葉酸受容体アルファ抗体およびその使用
MX2020009522A (es) 2018-03-13 2020-10-22 Phanes Therapeutics Inc Anticuerpos anti-folato del receptor 1 y usos de los mismos.
CA3103369A1 (en) * 2018-06-18 2019-12-26 Medimmune Limited Combination of lif inhibitors and platinum-based antineoplastic agents for use in treating cancer
CN110221052B (zh) * 2019-06-17 2022-09-23 昆山德诺瑞尔生物科技有限公司 Ppfibp1蛋白在制备肝癌术后预后评估试剂盒中的应用
US20250177550A1 (en) * 2022-03-11 2025-06-05 Astrazeneca Ab A scoring method for an anti-fr alpha antibody drug conjugate therapy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050232919A1 (en) * 2004-02-12 2005-10-20 Morphotek, Inc. Monoclonal antibodies that specifically block biological activity of a tumor antigen
JP2009521206A (ja) * 2005-04-22 2009-06-04 モルフォテック、インク. 免疫エフェクター活性を有する葉酸受容体アルファ陽性細胞に内部移行する抗体
GB0718167D0 (en) * 2007-09-18 2007-10-31 Cancer Rec Tech Ltd Cancer marker and therapeutic target
RU2630608C2 (ru) 2010-11-05 2017-09-11 Морфотек Инк. Рецептор фолиевой кислоты альфа в качестве диагностического и прогностического маркера злокачественных опухолей, экспрессирующих рецептор фолиевой кислоты альфа
PL2731972T3 (pl) 2011-07-15 2018-06-29 Eisai R&D Management Co., Ltd. Przeciwciała skierowane przeciwko receptorowi folianowemu alfa i ich zastosowania

Also Published As

Publication number Publication date
RU2718780C9 (ru) 2020-07-08
EP3283886A1 (en) 2018-02-21
EP3283886B1 (en) 2020-01-15
RU2718780C2 (ru) 2020-04-14
KR20170137848A (ko) 2017-12-13
AU2016248222A1 (en) 2017-11-09
CN107624071A (zh) 2018-01-23
WO2016168440A1 (en) 2016-10-20
SG11201708546UA (en) 2017-11-29
JP2018516244A (ja) 2018-06-21
CA2983126A1 (en) 2016-10-20
US20180125970A1 (en) 2018-05-10
RU2017136863A3 (cg-RX-API-DMAC7.html) 2019-08-21
MX2017013390A (es) 2018-06-13
BR112017022320A2 (pt) 2018-07-24
RU2017136863A (ru) 2019-05-17

Similar Documents

Publication Publication Date Title
IL298497B1 (en) A method for treating cancer
IL323396A (en) Cancer treatment methods
IL289947A (en) A method for treating cancer
SG11201708861VA (en) Methods for treating cancer
IL260199B (en) Cancer treatment methods
IL255060A0 (en) Combined treatment for cancer
PL3553087T3 (pl) Terapia celowana nowotworu złośliwego płuc
IL253573A0 (en) Combined therapies for the treatment of cancers
SMT202200370T1 (it) Composizione per il trattamento del cancro
IL257691A (en) A method for treating cancer
IL256836B (en) Methods for treating cancer using apilimod
IL254393A0 (en) Methods for treating diseases associated with pathological changes in protein
IL255022A0 (en) Cancer treatment methods
IL255079A0 (en) Methods of treating lung cancer
IL246558A0 (en) New methods of cancer treatment
IL255018A0 (en) Cancer treatment methods
IL255016A0 (en) Cancer treatment methods
SG10201508795XA (en) Method for treating cancer
HK1262621A1 (en) Methods for treating cancer
HK1262818A1 (en) Methods for treating cancer
AU2015903130A0 (en) Methods for treating tumours